Shock States

Pediatric Critical Care

Volumn , Issue , 2006, Pages 394-410

  Smith, Lincoln ^a   Hernan, Lynn ^b,c  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961166265     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032301808-1.50030-4     Document Type: Chapter

References (132)

1. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685-691.
2. Ackland G, Grocott MP, Mythen MG Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit Care 2000, 4:269-281.
3. Alston TA Sepsis and hypovolemia: two bad. Crit Care Med 2003, 31:991-992.
4. Altura BM, Altura BT Vascular smooth muscle and neurohypophyseal hormones. Fed Proc 1977, 36:1853-1860.
5. Annane D Corticosteroids for septic shock. Crit Care Med 2001, 29(7 suppl):S117-S120.
6. Arques S, Ambrosi P, Gelisse R, et al. Prevalence of angiographic coronary artery disease in patients hospitalized for acute diastolic heart failure without clinical and electrocardiographic evidence of myocardial ischemia on admission. Am J Cardiol 2004, 94:133-135.
7. Bartelstone HJ, Nasmyth PA Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip. Am J Physiol 1965, 208:754-762.
8. Barton P, Kalil AC, Nadel S, et al. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics 2004, 113(1 pt 1):7-17.
9. Begany DP, Carcillo JA, Herzer WA, et al. Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure. J Pharmacol Exp Ther 1996, 278:37-41.
10. Benedict CR Neurohumoral aspects of heart failure. Cardiol Clin 1994, 12:9-23.
11. Berg RA, Donnerstein RL, Padbury JF Dobutamine infusions in stable, critically ill children: pharmacokinetics and hemodynamic actions. Crit Care Med 1993, 21:678-686.
12. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
13. Best C, Walsh J, Sinclair J, Beattie J Early haemo-diafiltration in meningococcal septicaemia. Lancet 1996, 347:201-202.
14. Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994, 331:1105-1109.
15. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
16. Bower RH Nutrition during critical illness and sepsis. New Horiz 1993, 1:348-352.
17. Brecker SJ, Xiao HB, Mbaissouroum M, Gibson DG Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy. Am J Cardiol 1993, 71:203-209.
18. Bruins MJ, Deutz NE, Soeters PB Aspects of organ protein, amino acid and glucose metabolism in a porcine model of hypermetabolic sepsis. Clin Sci (Lond) 2003, 104:127-141.
19. Busund R, Koukline V, Utrobin U, Nedashkovsky EP Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002, 28:1434-1439.
20. Cairns CB Rude unhinging of the machinery of life: metabolic approaches to hemorrhagic shock. Curr Opin Crit Care 2001, 7:437-443.
21. Califf RM, Bengtson JR Cardiogenic shock. N Engl J Med 1994, 330:1724-1730.
22. Carcillo JA, Davis AL, Zaritsky A Role of early fluid resuscitation in pediatric septic shock. JAMA 1991, 266:1242-1245.
23. Carcillo JA, Fields AI Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. J Pediatr (Rio J) 2002, 78:449-466.
24. Carcillo JA, Kellum JA Is there a role for plasmapheresis/plasma exchange therapy in septic shock, MODS, and thrombocytopenia-associated multiple organ failure? We still do not know but perhaps we are closer. Intensive Care Med 2002, 28:1373-1375.
25. Ceneviva G, Paschall JA, Maffei F, Carcillo JA Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998, 102:e18-e19.
26. Cerra FB, Maddaus MA, Dunn DL, et al. Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. Arch Surg 1992, 127:163-167.
27. Chendrasekhar A, Pillai S, Fagerli JC, et al. Rectal pH measurement in tracking cardiac performance in a hemorrhagic shock model. J Trauma Injury Infect Crit Care 1996, 40:963-967.
28. Chinkes D, deMelo E, Zhang XJ, et al. Increased plasma glucose clearance in sepsis is due to increased exchange between plasma and interstitial fluid. Shock 1995, 4:356-360.
29. Cilley RE, Scharenberg AM, Bongiorno PF, et al. Low oxygen delivery produced by anemia, hypoxia, and low cardiac output. J Surg Res 1991, 51:425-433.
30. Cockerill FR, Muller SR, Anhalt JP, et al. Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med 1992, 117:545-553.
31. Cohen J The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
32. Cohn SM, Varela JE, Giannotti G, et al. Splanchnic perfusion evaluation during hemorrhage and resuscitation with gastric near-infrared spectroscopy. J Trauma Injury Infect Crit Care 2001, 50:629-634. discussion 634-635.
33. Cooper MS, Stewart PM Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003, 348:727-734.
34. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 23:1430-1439.
35. Crouser ED, Dorinsky PM Metabolic consequences of sepsis. Correlation with altered intracellular calcium homeostasis. Clin Chest Med 1996, 17:249-261.
36. Das UN Critical advances in septicemia and septic shock. Crit Care 2000, 4:290-296.
37. De Bruin WJ, Greenwald BM, Notterman DA Fluid resuscitation in pediatrics. Crit Care Clin 1992, 8:423-438.
38. Deitch EA The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990, 125:403-404.
39. Despond O, Proulx F, Carcillo JA, Lacroix J Pediatric sepsis and multiple organ dysfunction syndrome. Curr Opin Pediatr 2001, 13:247-253.
40. Dujardin KS, McCully RB, Wijdicks EF, et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 2001, 20:350-357.
41. Fabian TC, Boucher BA, Croce MA, et al. Pneumonia and stress ulceration in severely injured patients. A prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993, 128:185-191.
42. Fink MP Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001, 17:219-237.
43. Fink MP Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration? Crit Care Clin 2002, 18:165-175.
44. Fink MP Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis. Crit Care Med 1991, 19:627-641.
45. Finney SJ, Evans TW Emerging therapies in severe sepsis. Thorax 2002, 57(suppl 2):II8-II14.
46. Flancbaum L, Choban PS, Dasta JF Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994, 22:61-68.
47. Fourrier F, Chopin C, Huart JJ, et al. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993, 104:882-888.
48. Gaasch WH Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 1994, 271:1276-1280.
49. Giroir BP Recombinant human activated protein C for the treatment of severe sepsis: is there a role in pediatrics?. Curr Opin Pediatr 2003, 15:92-96.
50. Giroir BP Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 1993, 21:780-789.
51. Gutierrez G, Lund N, Bryan-Brown CW Cellular oxygen utilization during multiple organ failure. Crit Care Clin 1989, 5:271-287.
52. Hamilton MA, Mythen MG Gastric tonometry: where do we stand?. Curr Opin Crit Care 2001, 7:122-1227.
53. Han YY, Carcillo JA, Dragotta MA, et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 2003, 112:793-799.
54. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003, 88:1082-1088.
55. Harding SE, MacLeod KT, Jones SM, et al. Contractile responses of myocytes isolated from patients with cardiomyopathy. Eur Heart J 1991, 12(suppl D):44-48.
56. Hatherill M, Tibby SM, Hilliard T, et al. Adrenal insufficiency in septic shock. Arch Dis Child 1999, 80:51-55.
57. Haupt MT, Kaufman BS, Carlson RW Fluid resuscitation in patients with increased vascular permeability. Crit Care Clin 1992, 341-353.
58. Holmes CL, Landry DW, Granton JT Science review: vasopressin and the cardiovascular system part 1 receptor physiology. Crit Care (Lond) 2003, 7:427-434.
59. Holmes CL, Landry DW, Granton JT cience review: vasopressin and the cardiovascular system part 2 clinical physiology. Crit Care (Lond) 2004, 8:15-23.
60. Holmes CL, Patel BM, Russell JA, Walley KR Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120:989-1002.
61. Hotchkiss RS, Karl IE The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
62. Hussain SN, Graham R, Rutledge F, Roussos C Respiratory muscle energetics during endotoxic shock in dogs. J Appl Physiol 1986, 60:486-493.
63. Jafari HS, McCracken GH Sepsis and septic shock: a review for clinicians. Pediatr Infect Dis J 1992, 11:739-748.
64. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of 'low-dose' hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003, 167:512-520.
65. Khandelwal P, Bohn D, Carcillo JA, Thomas NJ Pro/con clinical debate: do colloids have advantages over crystalloids in paediatric sepsis?. Crit Care 2002, 6:286-288.
66. Kinsella JP, Toews WH, Henry D, Abman SH Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J Pediatr 1993, 122(5 pt 1):803-806.
67. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002, 8:376-388.
68. Kuppermann N, Inkelis SH, Saladino R The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans. Pediatr Infect Dis J 1994, 13:867-873.
69. Lang R Medical management of chronic heart failure: inotropic, vasodilator, or inodilator drugs?. Am Heart J 1990, 120(6 pt 2):1558-1564.
70. Lawless ST, Zaritsky A, Miles M The acute pharmacokinetics and pharmacodynamics of amrinone in pediatric patients. J Clin Pharmacol 1991, 31:800-803.
71. Lefering R, Neugebauer EA Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995, 23:1294-1303.
72. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
73. Lewis MA Veno-venous haemodiafiltration in meningococcal septicaemia. Lancet 1996, 347:612-613. 2.
74. Maitra SR, Wojnar MM, Lang CH Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock 2000, 13:379-385.
75. Marik PE Sublingual capnography: a clinical validation study. Chest 2001, 120:923-927.
76. Marik PE, Zaloga GP Adrenal insufficiency during septic shock. Crit Care Med 2003, 31:141-145.
77. McCloskey RV, Straube RC, Sanders C, et al. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. Ann Intern Med 1994, 121:1-5.
78. McKinley BA, Marvin RG, Cocanour CS, Moore FA Tissue hemoglobin O2 saturation during resuscitation of traumatic shock monitored using near infrared spectrometry. J Trauma Injury Infect Crit Care 2000, 48:637-642.
79. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001, 103:2254-2259.
80. Medina P, Acuna A, Martinez-Leon JB, et al. Arginine vasopressin enhances sympathetic constriction through the V1 vasopressin receptor in human saphenous vein. Circulation 1998, 97:865-870.
81. Medina P, Noguera I, Aldasoro M, et al. Enhancement by vasopressin of adrenergic responses in human mesenteric arteries. Am J Physiol 1997, 272(3 pt 2):H1087-H1093.
82. Mink RB, Pollack MM Effect of blood transfusion on oxygen consumption in pediatric septic shock. Crit Care Med 1990, 18:1087-1091.
83. Moller JH, Hoffman JIE Congestive heart failure pediatric cardiovascular medicine 2000, Churchill Livingstone, New York.
84. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 1992, 216:172-183.
85. Mouchawar A, Rosenthal M A pathophysiological approach to the patient in shock. Int Anesthesiol Clin 1993, 31:1-20.
86. Murphy MB, Elliott WJ Dopamine and dopamine receptor agonists in cardiovascular therapy. Crit Care Med 1990, 18(1 pt 2):S14-S18.
87. Myles PS, Buckland MR, Schenk NJ, et al. Effect of 'renal-dose' dopamine on renal function following cardiac surgery. Anaesth Intensive Care 1993, 21:56-61.
88. Natanson C, Hoffman WD, Suffredini AF, et al. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994, 120:771-783.
89. Nguyen TC, Hall MW, Han YY, et al. A randomized control trial of plasma exchange therapy in pediatric patients with thrombocytopenia associated multiple organ failure. Soc Pediatr Res 2001, 49:42A.
90. Om A, Hess ML Inotropic therapy of the failing myocardium. Clin Cardiol 1993, 16:5-14.
91. Opal SM, Esmon CT Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003, 7:23-38.
92. Pacher R, Globits S, Wutte M, et al. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study. Crit Care Med 1994, 22:1084-1090.
93. Packer M Treatment of chronic heart failure. Lancet 1992, 340:92-95.
94. Packer M Pathophysiology of chronic heart failure. Lancet 1992, 340:88-92.
95. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990, 97:126-131.
96. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990, 113:227-242.
97. Patel BM, Chittock DR, Russell JA, Walley KR Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96:576-582.
98. Pearson G, Khandelwal PC, Naqvi N Early filtration and mortality in meningococcal septic shock?. Arch Dis Child 2000, 83:508-509.
99. Pinsky MR Beyond global oxygen supply-demand relations: in search of measures of dysoxia. Intensive Care Med 1994, 20:1-3.
100. Porembka DT Cardiovascular abnormalities in sepsis. New Horiz 1993, 1:324-341.
101. Power C, Fanning N, Redmond HP Cellular apoptosis and organ injury in sepsis: a review. Shock 2002, 18:197-211.
102. Preiser JC, Devos P, Van den BG Tight control of glycaemia in critically ill patients. Curr Opin Clin Nutr Metab Care 2002, 5:533-537.
103. Rackow EC, O'Neil P, Astiz ME, Carpati CM Sublingual capnometry and indexes of tissue perfusion in patients with circulatory failure. Chest 2001, 120:1633-1638.
104. Reeves JH A review of plasma exchange in sepsis. Blood Purif 2002, 20:282-288.
105. Reeves JH, Butt WW, Shann F, et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999, 27:2096-2104.
106. Reidy JJ, Ramsay G Clinical trials of selective decontamination of the digestive tract: review. Crit Care Med 1990, 18:1449-1456.
107. Reilly PM, Bulkley GB Vasoactive mediators and splanchnic perfusion. Crit Care Med 1993, 21(2 suppl):S55-S68.
108. Reinelt H, Radermacher P, Fischer G, et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997, 86:818-824.
109. Reinhart K, Karzai W Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 2001, 29(7 suppl):S121-S125.
110. Rich GF, Murphy GD, Roos CM, Johns RA Inhaled nitric oxide. Selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993, 78:1028-1035.
111. Ringe HI, Varnholt V, Gaedicke G Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediatr Crit Care Med 2003, 4:471-475.
112. Saez-Llorens X, McCracken GH Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr 1993, 123:497-508.
113. Schmidt J, Mann S, Mohr VD, et al. Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis. Intensive Care Med 2000, 26:532-537.
114. Schumacker PT, Samsel RW Oxygen delivery and uptake by peripheral tissues: physiology and pathophysiology. Crit Care Clin 1989, 5:255-269.
115. Schuster DP Stress ulcer prophylaxis: in whom?. With what? Crit Care Med 1993, 21:4-6.
116. Schwangel DA, Nichols DG, Cameron DE Coarctation of the aorta and interrupted aortic arch. Critical heart disease in infants and children 1995, Mosby-Year Book, St. Louis. D.G. Nichols, D.E. Cameron, W.J. Greeley, D.G. Lappe, R.M. Underleider, R.C. Wetzel (Eds.).
117. Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med 2003, 31:1752-1758.
118. Sharshar T, Carlier R, Blanchard A, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002, 30:497-500.
119. Stegmayr B Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome. Clin Chem Lab Med 1999, 37:327-332.
120. Stouffer GA, Sheahan RG, Lenihan DJ, et al. The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin. Am J Med Sci 2003, 326:369-374.
121. Streefkerk JO, Mathy MJ, Pfaffendorf M, van Zwieten PA Vasopressin-induced presynaptic facilitation of sympathetic neurotransmission in the pithed rat. J Hypertens 2002, 20:1175-1180.
122. Tang W, Weil MH, Sun S, et al. Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med 1993, 21:1046-1050.
123. Van den BG, de ZF, Lauwers P Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994, 22:1747-1753.
124. Van den BG, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
125. Verderber A, Gallagher KJ Effects of bathing, passive range-of-motion exercises, and turning on oxygen consumption in healthy men and women. Am J Crit Care 1994, 3:374-381.
126. Viires N, Sillye G, Aubier M, et al. Regional blood flow distribution in dog during induced hypotension and low cardiac output. Spontaneous breathing versus artificial ventilation. J Clin Invest 1983, 72:935-947.
127. Vincent JL, Abraham E, Annane D, et al. Reducing mortality in sepsis: new directions. Crit Care 2002, 6(suppl 3):S1-18.
128. Vincent JL, Angus DC, Artigas A, et al. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003, 31:834-840.
129. Wagner BK, D'Amelio LF Pharmacologic and clinical considerations in selecting crystalloid, colloidal, and oxygen-carrying resuscitation fluids, part 1. Clin Pharm 1993, 12:335-346.
130. Wagner BK, D'Amelio LF Pharmacologic and clinical considerations in selecting crystalloid, colloidal, and oxygen-carrying resuscitation fluids, part 2. Clin Pharm 1993, 12:415-428.
131. Watson RS, Carcillo JA, Linde-Zwirble WT, et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003, 167:695-701.
132. Yan SB, Helterbrand JD, Hartman DL, et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001, 120:915-922.